Cleveland Clinic researchers report that the drug torcetrapib, despite raising high density lipoprotein cholesterol (HDL) or the “good” cholesterol by more than 60%, did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe.
Pfizer announced that new data regarding the effect of Lipitor (atorvastatin calcium) on atherosclerosis, cardiovascular events such as heart attacks and strokes, and health economics will be presented next week at the American College of Cardiology annual meeting in New Orleans.
The use of medicines to fight cardiovascular disease has been a primary focus of research in this area for the past several decades, as combinations of interventions and medicinal therapy have gradually begun to increase long-term survival rates.
In the study of 500,000 adults, the Asia-Pacific Cohort Studies Collaboration (APCSC) shows that the risks of dying from lung cancer were about twenty times higher among women who smoke compared with male smokers, a worrying finding given the increasing trend for women to take up the habit in many countries.
The Parkinson?s Institute will participate in a large-scale national clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson’s disease (PD). While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance.
In the study of 500,000 adults, published in the American Journal of Epidemiology, the Asia-Pacific Cohort Studies Collaboration (APCSC) shows that the risks of dying from lung cancer were about twenty times higher among women who smoke compared with male smokers, a worrying finding given the increasing trend for women to take up the habit in many countries.
A fibrous protein called fibrinogen, found in circulating blood and important in blood clotting, can promote multiple sclerosis (MS) when it leaks from the blood into the brain, triggering inflammation that leads to MS-related nerve damage.
At age 32, Maggie Fermental suffered a stroke that left her right side paralyzed. After a year and a half of conventional therapy with minimal results, she tried a new kind of robotic therapy developed by MIT engineers. A study to appear in the April 2007 issue of the American Journal of Physical Medicine & Rehabilitation shows that the device, which helped Fermental, also had positive results for five other severe stroke patients in a pilot clinical trial.
Patients with arterial disease have relatively high rates of experiencing a cardiovascular event (such as heart attack, stroke or cardiovascular death) within one year, and these increase with the number of arterial locations afflicted, according to a large, international study in the March 21 issue of JAMA.
Ex-smokers achieved non-smokers? level of arterial stiffness after a decade of smoking cessation, in a cross-sectional study reported in Hypertension: Journal of the American Heart Association.